Allergy Asthma and Clinical Immunology · 2018 · 76 citations · 20 references
Veterinary MedicineInternal MedicineInflammationPulmonary Function TestingPulmonologyAsthma ManagementEosinophilic DisordersPulmonary InflammationRespiratory DiseaseRespiratory PathophysiologyAsthma DiagnosisAsthmatic Airway InflammationEosinophil-mediated InflammationEosinophilic Airway DiseaseExhaled Nitric OxideNitric OxidePeripheral EosinophiliaSputum Induction
BACKGROUND: The fractional exhaled nitric oxide (FeNO) and blood eosinophils are biomarkers of eosinophilic airway inflammation used in the diagnosis and management of asthma, although induced sputum is the gold standard test for phenotypic asthma. Nevertheless, the clinical application of the correlation between sputum eosinophils, FeNO and blood eosinophils is controversial. OBJECTIVE: To investigate the clinical application of the correlation between sputum eosinophils, FeNO and blood eosinophils with uncontrolled asthmatic patients. It also examined the relationships between these biomarkers in bronchial reversibility and bronchial hyper-responsiveness (BHR). METHODS: This study evaluated 75 uncontrolled asthmatic patients (symptom control and future risk of adverse outcomes). All patients underwent the following on the same day: FeNO, spirometry, BHR or bronchodilator reversibility, sputum induction and blood collection. Eosinophilic airway inflammation was defined as sputum eosinophils ≥ 2.5% or FeNO levels ≥ 32 parts per billion (ppb). RESULTS: A significant positive relationship was between percentage of sputum eosinophils and FeNO (r = 0.4556; p < 0.0001) and percentage of blood eosinophils (r = 0.3647; p = 0.0013), and a significant negative correlation was between percentage of sputum neutrophils and FeNO (r = - 0.3653; p = 0.0013). No relationship between FeNO and percentage of blood eosinophils (p = 0.5801). ROC curve analysis identified FeNO was predictive of sputum eosinophilia [area under the curve (AUC) 0.707, p = 0.004] at a cutoff point of 35.5 ppb (sensitivity = 67.3%, specificity = 73.9%). Percentage of blood eosinophils was also highly predictive with an AUC of 0.73 (p = 0.002) at a cut-off point of 1.5%, sensitivity and specificity were 61.5 and 78.3%, respectively. Although the sputum neutrophil percentage was correlated with FeNO, ROC curve of these parameters did not show useful values (AUC = 0.297, p = 0.003; AUC = 0.295, p = 0.021). CONCLUSIONS AND CLINICAL RELEVANCE: Blood eosinophils and FeNO can accurately predict eosinophilic airway inflammation in uncontrolled asthmatic patients. FeNO is poor surrogates for sputum neutrophils and blood eosinophils. The FeNO level and blood eosinophils, which determine an optimal cutoff for sputum eosinophilia, need more studies.
20
Raed A. Dweik, Peter B. Boggs, Serpil C. Erzurum et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 2.5K citations
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
Jodie L. Simpson, Rodney J. Scott, Michael Boyle et al. · Respirology · 2006 · 939 citations
Donald Payne, Ian M. Adcock, Nicola Wilson et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 465 citations
Medicine, Child Health, Pediatrics +15
M A Berry, Dominick Shaw, R. H. Green et al. · Clinical & Experimental Allergy · 2005 · 321 citations · Full text